Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

197.500
+14.2007.75%
Volume:1.73M
Turnover:337.52M
Market Cap:17.94B
PE:-4.24
High:200.200
Open:183.700
Low:183.700
Close:183.300
52wk High:493.800
52wk Low:158.500
Shares:90.83M
HK Float Shares:90.83M
Volume Ratio:1.99
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-46.603
ROE:-65.93%
ROA:-24.28%
PB:10.56
PE(LYR):-4.24
PS:18.19

Loading ...

Movement Alert|Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD

Market Focus
·
May 28

DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech

Stock News
·
May 27

Movement Alert|Duality Biotherapeutics-B Rises 5.36% in Regular Trading, Buyback Execution and Institutional Accumulation Boost Confidence

Market Focus
·
May 27

DUALITYBIO-B (09606) Spends HK$6.5144 Million on Share Buyback

Stock News
·
May 26

LAV Asset Management Boosts Stake in DUALITYBIO-B with 105,000 Share Purchase

Stock News
·
May 26

Duality Biotherapeutics Launches $40 Million Stock Buyback; Shares Rise 3%

MT Newswires Live
·
May 20

DualityBio-B Surges Nearly 5% in Morning Trading, Announces Up to $40 Million Share Buyback Plan

Deep News
·
May 20

Movement Alert|Duality Biotherapeutics Rises 5.66% in Regular Trading, Share Buyback Plan Triggers Rebound After Multi-Day Selloff

Market Focus
·
May 20

DUALITYBIO-B (09606) Announces Up to $40 Million Share Buyback, Founder Plans Additional $5 Million Purchase

Stock News
·
May 19

Duality Biotherapeutics Inc - Announces Share Repurchase Plan of up to $40 Mln

THOMSON REUTERS
·
May 19

DUALITYBIO-B Exercises Option for U.S. Cost and Profit/Loss Sharing on DB-1311/BNT324

Stock News
·
May 13

Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech

Bulletin Express
·
May 13

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant

Bulletin Express
·
May 07

Duality Biotherapeutics shareholders approved RMB share issue plan at EGM

Reuters
·
Apr 29

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

DUALITYBIO-B 2025年度:营收约18.52亿元小幅下滑,净亏损增至25.95亿元,股本由负转正

Bulletin Express
·
Apr 26

DualityBio publishes 2025 ESG report

Reuters
·
Apr 26

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

Stock News
·
Apr 16